Skip to content

Income Tax at other companies

BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$35.68M-31.9%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$1M0.0%
XER
Xeris Biopharma Holdings, Inc.XERS
$0
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$20K-73.0%
Theravance Biopharma logo
Theravance BiopharmaTBPH
-$1.54M-175%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$10.73M+149%

Segments

By segment

See full
Reportable Segment-$6.91M-485%

Other financials

Income statement

See full
Revenue$36.2M+77.5%
Gross profit$34.3M+80.1%
Operating income$52.1M+1,073%
Net income$37.9M+1,323%
EPS (diluted)$0.60+1,100%

Balance sheet

See full
Cash & equivalents$95.6M+156%
Total debt$1.1M-98.1%
Total equity$205.8M+402%
Total assets$278.6M+61.3%

Cash flow

See full
Operating cash flow$6.1M+175%
CapEx$35.0K-64.6%
Free cash flow$6.1M+173%

Valuation

See full
Market cap$773.23M+56.4%
Enterprise value$678.78M+30.8%
P/E6.2×
P/S6.3×-5.9×

Profitability

See full
Gross margin86.1%+7.2pp
Operating margin-103.9%-43.0pp
Net margin101.6%+60.1pp
FCF margin-75%-30.5pp

Returns & leverage

See full
Return on equity100.7%+60.3pp
Debt / equity-1.5×
Current ratio4.9×+1.9×

Where this comes from

Reported directly by Zevra Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zevra Therapeutics, Inc.'s income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zevra Therapeutics, Inc.'s income tax?
Zevra Therapeutics, Inc. (ZVRA) reported income tax of $6.91M in Q1 2026.
How has Zevra Therapeutics, Inc.'s income tax changed year-over-year?
Zevra Therapeutics, Inc.'s income tax increased by 484.9% year-over-year, from $1.18M to $6.91M.
What is the long-term trend for Zevra Therapeutics, Inc.'s income tax?
Over 3 years (2021 to 2025), Zevra Therapeutics, Inc.'s income tax has grown at a 366.4% compound annual growth rate (CAGR), from $34K to $3.45M.
What does income tax mean?
Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.